Where to Buy
Leal is stocked at 150 licensed dispensaries across New York and Michigan, 147 of them in New York, with the deepest coverage in New York, Queens, Brooklyn, Staten Island, and Buffalo. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In August 2026, Leal concentrated 69.30% share in Flower with year-over-year growth of 30.04% but month-over-month contraction of 4.16%, while Pre-Roll held 30.65% share with a 13.38% YoY decline yet a 13.17% MoM rebound; Vapor Pens remained marginal at 0.05% share with a 7.24% YoY decline. Despite brand-level sales up 12.70% YoY and average price up 17.64% YoY, category dynamics were mixed: Flower’s higher average price of $44.73 contrasts with Pre-Roll’s $8.73, signaling a volume-to-value trade-off as mix tilts toward higher-ticket Flower and away from smaller-ticket formats. The pattern implies Leal is leaning into premiumized Flower in New York, accepting Pre-Roll volatility to protect overall value density, which could cap short-term unit momentum but support revenue efficiency.
Positionally, holding rank 2 in Flower in New York aligns with the 30.04% Flower YoY growth and 69.30% mix weight, even as the 4.16% MoM dip introduces near-term share risk; the offsetting 13.17% MoM lift in Pre-Roll provides a hedge but its 13.38% YoY decline limits carry-through. With Vapor Pens at 0.05% share and down 7.24% YoY, Leal’s portfolio is effectively a two-category barbell, where premium-price Flower absorbs pricing power while Pre-Roll acts as a tactical traffic driver; the implication is a need to defend Flower rank while selectively restoring Pre-Roll’s annual trajectory to stabilize mix and sustain the 12.70% brand YoY growth.
Competitive Landscape
Leal sits at rank #2 in NY Flower in August 2026 after climbing 5 positions year over year from #7, while holding #2 for the past three months and matching its peak rank of #2 in August 2026; in contrast, Find. moved from #6 to #1 with 30.7% YoY sales growth and Untitled improved from #9 to #3 on 32.6% YoY growth, as Grassroots surged from #14 to #4 with 88.7% YoY growth while Rolling Green Cannabis slipped from #2 to #5 with a 36.2% YoY sales decline; this pattern implies Leal’s ascent is driven more by sustained rank stability against a widening gap above and volatility below than by outsized growth, signaling a need to defend #2 against faster climbers while plotting selective moves to challenge #1.

Notable Products
Gorilla Zkittlez Pre-Roll (1g) posted the standout move in August 2026 with a 189.9% month-over-month surge to rank 1, while Hella Jelly Pre-Roll (1g) slipped 18.1% to rank 3. Two more double-digit risers powered the reshuffle as Lemon Venom Pre-Roll (1g) climbed 78.7% to rank 4 and Thin Mint GSC Pre-Roll (1g) rose 54.0% to rank 5, indicating momentum concentrated in a few SKUs rather than across the board. With all top-10 items landing in the Pre-Roll category and only modest movement from Animal Face Pre-Roll (1g) at 3.2% in rank 7, the lineup skews toward quick-turn formats with room to prune underperformers. This pattern implies Leal is consolidating demand in a narrow set of high-velocity pre-roll SKUs, suggesting a strategy to double down on leading strains while culling slower movers.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.







